Summary
Differentials
Common
- Polycystic ovary syndrome
- Idiopathic hirsutism
Uncommon
- Hyperprolactinaemia
- Non-classical congenital adrenal hyperplasia
- Cushing's syndrome
- Androgenic drugs
- Androgen-secreting ovarian tumour
- Ovarian hyperthecosis
- Adrenocortical carcinoma
Contributors
Authors
Stephen L. Atkin, PhD, FRCP
Professor of Medicine
Head of School of Postgraduate Studies & Research
The Royal College of Surgeons in Ireland - Bahrain
Busaiteen
Bahrain
Disclosures
SLA has no competing interests.
Thozhukat Sathyapalan, MD, MRCP FRCPE
Professor of Endocrinology/Honorary Consultant Endocrinologist
Academic Endocrinology, Diabetes and Metabolism
Hull York Medical School
Michael White Diabetes Centre
Hull Royal Infirmary
Hull
UK
Disclosures
TS declares that he has received educational grants and clinical trials funding from Novo Nordisk, Eli Lillly, and Novartis.
Acknowledgements
Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic.
Disclosures
SB and MBB declared that they had no competing interests.
Peer reviewers
Joe McKenna, MD
Professor of Investigative Endocrinology
University College
Dublin
Ireland
Disclosures
JM declares that he has no competing interests.
Udaya Kabadi, MD, FRCP(C), FACP, FACE
Director
Endocrinology
Department of Internal Medicine
VA Medical Center
University of Iowa
Iowa City
IA
Disclosures
UK declares that he has no competing interests.
References
Key articles
Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233-57.Full text Abstract
Elliott J, Liu K, Motan T. Guideline no. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can. 2023 Dec;45(12):102272. Abstract
Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 International Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023 Oct;120(4):767-93.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Guidelines
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Guideline no. 444: hirsutism: evaluation and treatment
More GuidelinesPatient information
Polycystic ovary syndrome
Ovarian cancer
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer